The estimated Net Worth of Albert Bourla is at least $36.5 Million dollars as of 23 February 2024. Albert Bourla owns over 127,674 units of Pfizer stock worth over $13,042,926 and over the last 11 years he sold PFE stock worth over $5,557,386. In addition, he makes $17,929,000 as Chairman of the Board and Chief Executive Officer at Pfizer.
Albert has made over 20 trades of the Pfizer stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 127,674 units of PFE stock worth $3,490,607 on 23 February 2024.
The largest trade he's ever made was exercising 222,328 units of Pfizer stock on 15 December 2022 worth over $6,058,438. On average, Albert trades about 4,489 units every 12 days since 2014. As of 23 February 2024 he still owns at least 439,748 units of Pfizer stock.
You can see the complete history of Albert Bourla stock trades at the bottom of the page.
Dr. Albert Bourla Ph.D. serves as Chairman of the Board, Chief Executive Officer of the Company. Board member of Pharmaceutical Research and Manufacturers of America (PhRMA). Board member of the Pfizer Foundation, which promotes access to quality healthcare. Member of the Board of Directors of the Partnership for New York City and Catalyst, a global non-profit organization accelerating progress for the advancement of women into leadership.
As the Chairman of the Board and Chief Executive Officer of Pfizer, the total compensation of Albert Bourla at Pfizer is $17,929,000. There are no executives at Pfizer getting paid more.
Albert Bourla is 58, he's been the Chairman of the Board and Chief Executive Officer of Pfizer since 2020. There are 14 older and 14 younger executives at Pfizer. The oldest executive at Pfizer Inc. is Wyllie Don Cornwell, 72, who is the Independent Director.
Albert's mailing address filed with the SEC is 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK, NY, 10001-2192.
Over the last 12 years, insiders at Pfizer have traded over $216,003,942 worth of Pfizer stock and bought 24,324 units worth $872,198 . The most active insiders traders include Shantanu Narayen, Ian C Read, and James M Kilts. On average, Pfizer executives and independent directors trade stock every 12 days with the average trade being worth of $2,169,896. The most recent stock trade was executed by Jennifer B. Damico on 13 August 2024, trading 5,154 units of PFE stock currently worth $147,714.
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.
Pfizer executives and other stock owners filed with the SEC include: